CBD LIFE SCIENCES INC - CBDL STOCK NEWS

CBD Life Sciences (OTC PINK: CBDL) plans to launch its products on Alibaba by early October, expanding its reach in the e-commerce market. The company's offerings will include edibles, cartridges, and tinctures, enhancing its existing product line. President & CEO Lisa Nelson highlighted the potential for increased revenue and consumer traffic to their e-commerce store. The press release also noted the rapid growth of B2B e-commerce, with significant sales projections for the U.S. market. CBD Life Sciences is also nearing the opening of its third retail location.

CBD Life Sciences (OTC PINK: CBDL) is set to launch a new subscription program for its products by the end of this week, offering tailored boxes for various needs, including options for pets. This initiative aims to enhance customer choice and drive revenue growth. The subscription box industry has seen substantial growth, reaching over $10 billion in revenue by 2019. Additionally, the company is expanding with a third retail location and a recreational marijuana facility, which is expected to significantly boost revenue. The President & CEO expressed high expectations for the program's impact.

CBD Life Sciences (CBDL) is applying for an Agricultural Hemp License in Arizona through its subsidiary LBC Bioscience Inc.. This license will enable the company to establish a grow facility and explore diverse product offerings including flower, edibles, oils, and creams. President & CEO Lisa Nelson emphasized the potential for significant revenue growth, citing the versatility of hemp with over 25,000 uses. The global CBD market is projected to reach USD 13.4 billion by 2028 with a 21.2% CAGR. Additionally, CBD Life Sciences is nearing the opening of its third retail location.

SCOTTSDALE, AZ / ACCESSWIRE / August 18, 2021 / CBD Life Sciences (OTC PINK:CBDL) will participate in the White Label Expo in Las Vegas on September 1-2, showcasing its products to a projected audience of 15,000 attendees. The expo will feature 300 exhibitors and 200 seminars, focusing on innovations in white label goods. Lisa Nelson, President & CEO, expressed excitement for the opportunity to expand product reach. Additionally, CBD Life Sciences is nearing its third retail location, indicating significant growth potential. The company plans to keep its stakeholders informed on developments.

CBD Life Sciences (OTC PINK:CBDL) expands its product line with new Vegan, non-GMO Gluten Free Gummies, boasting 20mg of hemp extract per 4oz jar in flavors like candy apple and blue raspberry. CEO Lisa Nelson highlights a commitment to high-quality ingredients, catering to a wider demographic including vegans and those with dietary restrictions. The gummies aim to manage stress and enhance sleep. Soon available online and on Amazon, this launch coincides with the company's plans for a third retail location, indicating further revenue growth.

CBD Life Sciences (OTC PINK:CBDL) has announced the launch of new Delta-10 Cartridges through its subsidiary, LBC Bioscience Inc. Available in Sour Diesel and Blue Dream strains, each cartridge contains 900MG of Delta-10-THC. This cannabinoid is federally legal and is gaining popularity due to its uplifting effects without the paranoia associated with Delta-9-THC. Additionally, CBD Life Sciences is expanding its retail presence, nearing its third retail location and a recreational marijuana facility, contributing to potential revenue growth.

CBD Life Sciences (CBDL) has announced the launch of its new 3000MG Pain Relief Cream, significantly stronger than its previous 1200MG version. President & CEO Lisa Nelson emphasizes the cream's effectiveness for athletes and professionals, promising immediate relief without psychotropic effects. The product targets customers like athletes and healthcare professionals, offering localized pain relief. The company is also nearing its third retail location, hinting at future revenue growth.

CBD Life Sciences (OTC PINK: CBDL) has successfully opened its second retail location, The CBD Vault, on June 12, 2021, in Scottsdale, AZ. The grand opening attracted over 200 customers, with all four new strains of Delta-8 cartridges selling out within the first hour. The company plans further expansion, with third and fourth locations in Sedona and Las Vegas, and is exploring a recreational marijuana facility. This expansion is expected to drive revenue growth as CBD Life Sciences continues to enhance its product offerings and retail presence.

CBD Life Sciences (OTC PINK:CBDL) has appointed Matthew McGee as its new Chief Marketing Officer, effective immediately. McGee brings experience in the cannabis sector and a strong background in customer marketing strategies. He aims to enhance the company's growth and expand its sales. President & CEO Lisa Nelson expressed confidence in McGee's leadership capabilities. LBC Bioscience, a subsidiary of CBD Life Sciences, is already well-stocked with high-quality CBD products, including oils and wellness items, and is poised for further market expansion.